Abundance of Aβ(5-x) like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer’s disease

por Guzmán, Erika Avendaño, Bouter, Yvonne, Richard, Bernhard C, Lannfelt, Lars, Ingelsson, Martin, Paetau, Anders, Verkkoniemi-Ahola, Auli, Wirths, Oliver, Bayer, Thomas A
Publicado 2014

Interleukin‐12/23 deficiency differentially affects pathology in male and female Alzheimer's disease‐like mice

por Eede, Pascale, Obst, Juliane, Benke, Eileen, Yvon‐Durocher, Genevieve, Richard, Bernhard C, Gimber, Niclas, Schmoranzer, Jan, Böddrich, Annett, Wanker, Erich E, Prokop, Stefan, Heppner, Frank L
Publicado 2020

N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody

por Antonios, Gregory, Saiepour, Nasrin, Bouter, Yvonne, Richard, Bernhard C, Paetau, Anders, Verkkoniemi-Ahola, Auli, Lannfelt, Lars, Ingelsson, Martin, Kovacs, Gabor G, Pillot, Thierry, Wirths, Oliver, Bayer, Thomas A
Publicado 2013

Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models

por Reinert, Jochim, Richard, Bernhard C., Klafki, Hans W., Friedrich, Beate, Bayer, Thomas A., Wiltfang, Jens, Kovacs, Gabor G., Ingelsson, Martin, Lannfelt, Lars, Paetau, Anders, Bergquist, Jonas, Wirths, Oliver
Publicado 2016

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X

por Antonios, Gregory, Borgers, Henning, Richard, Bernhard C., Brauß, Andreas, Meißner, Julius, Weggen, Sascha, Pena, Vladimir, Pillot, Thierry, Davies, Sarah L., Bakrania, Preeti, Matthews, David, Brownlees, Janet, Bouter, Yvonne, Bayer, Thomas A.
Publicado 2015